Q32 Bio

1 follower

Q32 Bio is a biotechnology company developing therapies targeting powerful regulators of the innate and adaptive immune systems, with the goal of re-balancing the immune system in severe autoimmune and inflammatory diseases.






Org chart

Jodie Morrison
Acting CEO

Jodie Morrison

Shelia Violette
Co-Founder & Chief Scientific Officer
Jason Campagna
Chief Medical Officer
David Appugliese
SVP & Head of People
Maria Marzilli
EVP, Corporate Strategy & Program Operations
Amy Gubits
Senior Director Program Management
Bill Lundberg
Independent Director
Dessi McEntee, MS, DABT
Associate Director, Toxicology
Fei Liu
Associate Director
Hong Wu, MD, PhD, DABT
VP Head Of Clin Pharm Nonclinical Development
Isidora Tošić
New Product Planning Manager
Joel Scherer
Vice President, Clinical Development, Immunotherapeutics
Justin Rogers
Director, Quality Assurance
Reena Malik
Associate Director Regulatory Affairs
Richard Leigh-Pemberton
Vice President, Clinical Development
Theresa Carbeau
Director CMC